The Clinical Advisor spoke with NP Dallas Ducar about what clinicians can do amidst the current social and political landscape to adequately care for their transgender and gender-diverse patients.

Asthma health care initiatives face extinction following the Trump administration's mass layoffs, grant cancellations, and proposed budget cuts.

Researchers conducted a scoping review examining the mental health outcomes in youth exposed to medical and social gender affirming care.

Drugmaker Gilead Sciences is not only providing the shot in the US, but is also working with governments and health groups in the UK and low-income countries to make these products more available.

HealthDay News — Work context seems to be associated with cardiovascular disease (CVD) risk factors, with variation across race, ethnicity, and sex, according to a study published in BMC Public Health ...

The Clinical Advisor spoke with Carlos Gutiérrez, EdD, MMS, PA-C, about the impact of Executive Orders on LGBTQ+ health care.

Over the past 5 or 10 years, methylene blue has come to be touted online as a so-called nootropic agent – a substance that ...

The new vaccine is indicated for individuals who have been previously vaccinated with any COVID-19 vaccine and are 65 years or older, or 12 to 64 years of age with at least 1 underlying condition that ...

A 35-year-old man presents with a chief complaint of purple discoloration of his toes and associated skin lesions that have ...

Researchers used the US Mortality Database to assess the relationship between hypothyroidism and Alzheimer disease mortality.

The worse overall survival seen in transgender and gender-diverse patients may be due to treatment differences or non-breast cancer causes, researchers say.

Risk factors include prenatal smoking, high prepregnancy body mass index, high gestational weight gain, and high birth weight.